HSP90AA1 and cancer: To confirm that growth inhibition was due to the intended Hsp90 inhibitory mechanism, the ICPD 26, 34 and 47 compounds were assessed for their effects on the established molecular signature of Hsp90 inhibition in the HCT116 cancer cells [38].